Experimental and human studies on antimony metabolism : their relevance for the biological monitoring of workers exposed to inorganic antimony

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000nab a2200000 i 4500</leader>
    <controlfield tag="001">MAP20071016882</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20080418114817.0</controlfield>
    <controlfield tag="007">hzruuu---uuuu</controlfield>
    <controlfield tag="008">940119e19910201gbr||||    | |00010|eng d</controlfield>
    <datafield tag="035" ind1=" " ind2=" ">
      <subfield code="a">6800002811</subfield>
    </datafield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">873</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="0">
      <subfield code="a">Experimental and human studies on antimony metabolism</subfield>
      <subfield code="b">: their relevance for the biological monitoring of workers exposed to inorganic antimony</subfield>
      <subfield code="c">R. Bailly... [et al.]</subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">This paper summarises the results of experimental studies designed to assess the handling of inorganic trivalent Sb in vivo, in particular to determine whether, like arsenic, trivalent Sb is methylated, and to identify the best approach for the biological monitoring of workers exposed to Sb. Some aspects of the toxicokinetics of Sb after the voluntary ingestion of a trivalent Sb salt by a woman and the relation between Sb excretion in urine and the intensity of occupational exposure to pentavalent Sb compounds are also reported</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080576615</subfield>
      <subfield code="a">Medicina laboral</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080565541</subfield>
      <subfield code="a">Epidemiología</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080559410</subfield>
      <subfield code="a">Metabolismo</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080625054</subfield>
      <subfield code="a">Sustancias tóxicas y peligrosas</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080605278</subfield>
      <subfield code="a">Contaminantes químicos</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080549657</subfield>
      <subfield code="a">Antimonio</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080552824</subfield>
      <subfield code="a">Toxicidad</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20080008710</subfield>
      <subfield code="a">Bailly, R.</subfield>
    </datafield>
    <datafield tag="740" ind1="0" ind2=" ">
      <subfield code="a">British journal of industrial medicine</subfield>
    </datafield>
    <datafield tag="773" ind1="0" ind2=" ">
      <subfield code="t">British journal of industrial medicine</subfield>
      <subfield code="d">London and Margate</subfield>
      <subfield code="g">nº 2, February 1991 ; p. 93-97</subfield>
    </datafield>
  </record>
</collection>